CRISPR/Cas9 advances engineering of microbial cell factories

One of the key drivers for successful metabolic engineering in microbes is the efficacy by which genomes can be edited. As such there are many methods to choose from when aiming to modify genomes, especially those of model organisms like yeast and bacteria. In recent years, clustered regularly inter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolic engineering 2016-03, Vol.34, p.44-59
Hauptverfasser: Jakočiūnas, Tadas, Jensen, Michael K., Keasling, Jay D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 59
container_issue
container_start_page 44
container_title Metabolic engineering
container_volume 34
creator Jakočiūnas, Tadas
Jensen, Michael K.
Keasling, Jay D.
description One of the key drivers for successful metabolic engineering in microbes is the efficacy by which genomes can be edited. As such there are many methods to choose from when aiming to modify genomes, especially those of model organisms like yeast and bacteria. In recent years, clustered regularly interspaced palindromic repeats (CRISPR) and its associated proteins (Cas) have become the method of choice for precision genome engineering in many organisms due to their orthogonality, versatility and efficacy. Here we review the strategies adopted for implementation of RNA-guided CRISPR/Cas9 genome editing with special emphasis on their application for metabolic engineering of yeast and bacteria. Also, examples of how nuclease-deficient Cas9 has been applied for RNA-guided transcriptional regulation of target genes will be reviewed, as well as tools available for computer-aided design of guide-RNAs will be highlighted. Finally, this review will provide a perspective on the immediate challenges and opportunities foreseen by the use of CRISPR/Cas9 genome engineering and regulation in the context of metabolic engineering. •Cas9 and gRNA expression was adopted for genome engineering of yeast and bacteria.CRISPR/Cas9 offers efficient marker-free integration of donor DNA in yeast.CRISPR/Cas9 and recombineering improves genome engineering efficiency in E. coliNuclease-deficient Cas9 was used for redirecting flux through biosynthetic pathways.•Cas9 and gRNA expression strategies have been adopted for genome engineering of yeast and bacteria.•CRISPR/Cas9 offers efficient integration of donor DNA without the use of markers in yeast.•CRISPR/Cas9 combined with recombineering improves genome engineering efficiency in E. coli.•Nuclease-deficient Cas9 can be used for redirecting flux through biosynthetic pathways.
doi_str_mv 10.1016/j.ymben.2015.12.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790954835</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1096717615001597</els_id><sourcerecordid>1763702488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-5b32ec428d924113d65a7c64e6a4f9ab504c507e549e6793aeea39d3402173123</originalsourceid><addsrcrecordid>eNqNkMtKAzEUhoMoVqtPIMgs3XTMyXUCupDipSAoVdchkzlTUjozNWkLvr1Tqy7F1TmL7z-Xj5AzoDlQUJfz_KMpsc0ZBZkDyynle-QIqFEjDYXY_-21GpDjlOaUAkgDh2TAlKZaCnpErsbTycvz9HLskslctXGtx5RhOwstYgztLOvqrAk-dmVwi8zjYpHVzq-6GDCdkIPaLRKeftchebu7fR0_jB6f7ifjm8eRF7JYjWTJGXrBisowAcArJZ32SqByojaulFR4STVKYVBpwx2i46bigjLQHBgfkovd3GXs3teYVrYJaXuKa7FbJwvaUCNFweU_UMU1ZaIoepTv0P65lCLWdhlD4-KHBWq3hu3cfhm2W8MWmO0N96nz7wXrssHqN_OjtAeudwD2RjYBo00-YK-1ChH9ylZd-HPBJxD9irk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1763702488</pqid></control><display><type>article</type><title>CRISPR/Cas9 advances engineering of microbial cell factories</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Jakočiūnas, Tadas ; Jensen, Michael K. ; Keasling, Jay D.</creator><creatorcontrib>Jakočiūnas, Tadas ; Jensen, Michael K. ; Keasling, Jay D.</creatorcontrib><description>One of the key drivers for successful metabolic engineering in microbes is the efficacy by which genomes can be edited. As such there are many methods to choose from when aiming to modify genomes, especially those of model organisms like yeast and bacteria. In recent years, clustered regularly interspaced palindromic repeats (CRISPR) and its associated proteins (Cas) have become the method of choice for precision genome engineering in many organisms due to their orthogonality, versatility and efficacy. Here we review the strategies adopted for implementation of RNA-guided CRISPR/Cas9 genome editing with special emphasis on their application for metabolic engineering of yeast and bacteria. Also, examples of how nuclease-deficient Cas9 has been applied for RNA-guided transcriptional regulation of target genes will be reviewed, as well as tools available for computer-aided design of guide-RNAs will be highlighted. Finally, this review will provide a perspective on the immediate challenges and opportunities foreseen by the use of CRISPR/Cas9 genome engineering and regulation in the context of metabolic engineering. •Cas9 and gRNA expression was adopted for genome engineering of yeast and bacteria.CRISPR/Cas9 offers efficient marker-free integration of donor DNA in yeast.CRISPR/Cas9 and recombineering improves genome engineering efficiency in E. coliNuclease-deficient Cas9 was used for redirecting flux through biosynthetic pathways.•Cas9 and gRNA expression strategies have been adopted for genome engineering of yeast and bacteria.•CRISPR/Cas9 offers efficient integration of donor DNA without the use of markers in yeast.•CRISPR/Cas9 combined with recombineering improves genome engineering efficiency in E. coli.•Nuclease-deficient Cas9 can be used for redirecting flux through biosynthetic pathways.</description><identifier>ISSN: 1096-7176</identifier><identifier>EISSN: 1096-7184</identifier><identifier>DOI: 10.1016/j.ymben.2015.12.003</identifier><identifier>PMID: 26707540</identifier><language>eng</language><publisher>Belgium: Elsevier Inc</publisher><subject>Bacteria ; Clustered Regularly Interspaced Short Palindromic Repeats - genetics ; CRISPR-Associated Proteins - genetics ; CRISPR-Cas Systems - genetics ; CRISPR/Cas9 ; Genetic Enhancement - methods ; Genome editing ; Genome, Microbial - genetics ; Metabolic engineering ; Metabolic Engineering - methods ; Metabolic Networks and Pathways - genetics ; Recombineering ; Yeast</subject><ispartof>Metabolic engineering, 2016-03, Vol.34, p.44-59</ispartof><rights>2015 International Metabolic Engineering Society</rights><rights>Copyright © 2015 International Metabolic Engineering Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-5b32ec428d924113d65a7c64e6a4f9ab504c507e549e6793aeea39d3402173123</citedby><cites>FETCH-LOGICAL-c458t-5b32ec428d924113d65a7c64e6a4f9ab504c507e549e6793aeea39d3402173123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ymben.2015.12.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26707540$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jakočiūnas, Tadas</creatorcontrib><creatorcontrib>Jensen, Michael K.</creatorcontrib><creatorcontrib>Keasling, Jay D.</creatorcontrib><title>CRISPR/Cas9 advances engineering of microbial cell factories</title><title>Metabolic engineering</title><addtitle>Metab Eng</addtitle><description>One of the key drivers for successful metabolic engineering in microbes is the efficacy by which genomes can be edited. As such there are many methods to choose from when aiming to modify genomes, especially those of model organisms like yeast and bacteria. In recent years, clustered regularly interspaced palindromic repeats (CRISPR) and its associated proteins (Cas) have become the method of choice for precision genome engineering in many organisms due to their orthogonality, versatility and efficacy. Here we review the strategies adopted for implementation of RNA-guided CRISPR/Cas9 genome editing with special emphasis on their application for metabolic engineering of yeast and bacteria. Also, examples of how nuclease-deficient Cas9 has been applied for RNA-guided transcriptional regulation of target genes will be reviewed, as well as tools available for computer-aided design of guide-RNAs will be highlighted. Finally, this review will provide a perspective on the immediate challenges and opportunities foreseen by the use of CRISPR/Cas9 genome engineering and regulation in the context of metabolic engineering. •Cas9 and gRNA expression was adopted for genome engineering of yeast and bacteria.CRISPR/Cas9 offers efficient marker-free integration of donor DNA in yeast.CRISPR/Cas9 and recombineering improves genome engineering efficiency in E. coliNuclease-deficient Cas9 was used for redirecting flux through biosynthetic pathways.•Cas9 and gRNA expression strategies have been adopted for genome engineering of yeast and bacteria.•CRISPR/Cas9 offers efficient integration of donor DNA without the use of markers in yeast.•CRISPR/Cas9 combined with recombineering improves genome engineering efficiency in E. coli.•Nuclease-deficient Cas9 can be used for redirecting flux through biosynthetic pathways.</description><subject>Bacteria</subject><subject>Clustered Regularly Interspaced Short Palindromic Repeats - genetics</subject><subject>CRISPR-Associated Proteins - genetics</subject><subject>CRISPR-Cas Systems - genetics</subject><subject>CRISPR/Cas9</subject><subject>Genetic Enhancement - methods</subject><subject>Genome editing</subject><subject>Genome, Microbial - genetics</subject><subject>Metabolic engineering</subject><subject>Metabolic Engineering - methods</subject><subject>Metabolic Networks and Pathways - genetics</subject><subject>Recombineering</subject><subject>Yeast</subject><issn>1096-7176</issn><issn>1096-7184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtKAzEUhoMoVqtPIMgs3XTMyXUCupDipSAoVdchkzlTUjozNWkLvr1Tqy7F1TmL7z-Xj5AzoDlQUJfz_KMpsc0ZBZkDyynle-QIqFEjDYXY_-21GpDjlOaUAkgDh2TAlKZaCnpErsbTycvz9HLskslctXGtx5RhOwstYgztLOvqrAk-dmVwi8zjYpHVzq-6GDCdkIPaLRKeftchebu7fR0_jB6f7ifjm8eRF7JYjWTJGXrBisowAcArJZ32SqByojaulFR4STVKYVBpwx2i46bigjLQHBgfkovd3GXs3teYVrYJaXuKa7FbJwvaUCNFweU_UMU1ZaIoepTv0P65lCLWdhlD4-KHBWq3hu3cfhm2W8MWmO0N96nz7wXrssHqN_OjtAeudwD2RjYBo00-YK-1ChH9ylZd-HPBJxD9irk</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Jakočiūnas, Tadas</creator><creator>Jensen, Michael K.</creator><creator>Keasling, Jay D.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>201603</creationdate><title>CRISPR/Cas9 advances engineering of microbial cell factories</title><author>Jakočiūnas, Tadas ; Jensen, Michael K. ; Keasling, Jay D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-5b32ec428d924113d65a7c64e6a4f9ab504c507e549e6793aeea39d3402173123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Bacteria</topic><topic>Clustered Regularly Interspaced Short Palindromic Repeats - genetics</topic><topic>CRISPR-Associated Proteins - genetics</topic><topic>CRISPR-Cas Systems - genetics</topic><topic>CRISPR/Cas9</topic><topic>Genetic Enhancement - methods</topic><topic>Genome editing</topic><topic>Genome, Microbial - genetics</topic><topic>Metabolic engineering</topic><topic>Metabolic Engineering - methods</topic><topic>Metabolic Networks and Pathways - genetics</topic><topic>Recombineering</topic><topic>Yeast</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jakočiūnas, Tadas</creatorcontrib><creatorcontrib>Jensen, Michael K.</creatorcontrib><creatorcontrib>Keasling, Jay D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Metabolic engineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jakočiūnas, Tadas</au><au>Jensen, Michael K.</au><au>Keasling, Jay D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CRISPR/Cas9 advances engineering of microbial cell factories</atitle><jtitle>Metabolic engineering</jtitle><addtitle>Metab Eng</addtitle><date>2016-03</date><risdate>2016</risdate><volume>34</volume><spage>44</spage><epage>59</epage><pages>44-59</pages><issn>1096-7176</issn><eissn>1096-7184</eissn><abstract>One of the key drivers for successful metabolic engineering in microbes is the efficacy by which genomes can be edited. As such there are many methods to choose from when aiming to modify genomes, especially those of model organisms like yeast and bacteria. In recent years, clustered regularly interspaced palindromic repeats (CRISPR) and its associated proteins (Cas) have become the method of choice for precision genome engineering in many organisms due to their orthogonality, versatility and efficacy. Here we review the strategies adopted for implementation of RNA-guided CRISPR/Cas9 genome editing with special emphasis on their application for metabolic engineering of yeast and bacteria. Also, examples of how nuclease-deficient Cas9 has been applied for RNA-guided transcriptional regulation of target genes will be reviewed, as well as tools available for computer-aided design of guide-RNAs will be highlighted. Finally, this review will provide a perspective on the immediate challenges and opportunities foreseen by the use of CRISPR/Cas9 genome engineering and regulation in the context of metabolic engineering. •Cas9 and gRNA expression was adopted for genome engineering of yeast and bacteria.CRISPR/Cas9 offers efficient marker-free integration of donor DNA in yeast.CRISPR/Cas9 and recombineering improves genome engineering efficiency in E. coliNuclease-deficient Cas9 was used for redirecting flux through biosynthetic pathways.•Cas9 and gRNA expression strategies have been adopted for genome engineering of yeast and bacteria.•CRISPR/Cas9 offers efficient integration of donor DNA without the use of markers in yeast.•CRISPR/Cas9 combined with recombineering improves genome engineering efficiency in E. coli.•Nuclease-deficient Cas9 can be used for redirecting flux through biosynthetic pathways.</abstract><cop>Belgium</cop><pub>Elsevier Inc</pub><pmid>26707540</pmid><doi>10.1016/j.ymben.2015.12.003</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1096-7176
ispartof Metabolic engineering, 2016-03, Vol.34, p.44-59
issn 1096-7176
1096-7184
language eng
recordid cdi_proquest_miscellaneous_1790954835
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Bacteria
Clustered Regularly Interspaced Short Palindromic Repeats - genetics
CRISPR-Associated Proteins - genetics
CRISPR-Cas Systems - genetics
CRISPR/Cas9
Genetic Enhancement - methods
Genome editing
Genome, Microbial - genetics
Metabolic engineering
Metabolic Engineering - methods
Metabolic Networks and Pathways - genetics
Recombineering
Yeast
title CRISPR/Cas9 advances engineering of microbial cell factories
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T07%3A52%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CRISPR/Cas9%20advances%20engineering%20of%20microbial%20cell%20factories&rft.jtitle=Metabolic%20engineering&rft.au=Jako%C4%8Di%C5%ABnas,%20Tadas&rft.date=2016-03&rft.volume=34&rft.spage=44&rft.epage=59&rft.pages=44-59&rft.issn=1096-7176&rft.eissn=1096-7184&rft_id=info:doi/10.1016/j.ymben.2015.12.003&rft_dat=%3Cproquest_cross%3E1763702488%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1763702488&rft_id=info:pmid/26707540&rft_els_id=S1096717615001597&rfr_iscdi=true